Upon completion of the Virtual Summit, participants will be able to:

• Apply a structured classification framework to distinguish liquid embolic agents — including conformable embolics, EVOH agents, cyanoacrylate glues, and emerging hydrogels — by mechanism, rheological properties, and clinical indication.
• Select the appropriate liquid embolic agent and technique for specific clinical scenarios, including trauma, venous disease, venous leak, tumor embolization, prostatic artery embolization, endoleak, and GI hemorrhage.
• Identify key technical considerations for safe and effective use of liquid embolics, including strategies to minimize reflux, manage flow dynamics, and apply combination approaches when appropriate.
• Evaluate the evidence base supporting emerging liquid embolic indications — including hydrogels for tumor embolization — and apply appropriate clinical judgment when translating emerging data into practice.
• Assess the economic and institutional factors affecting liquid embolic adoption, including cost-effectiveness considerations, formulary access, and reimbursement frameworks relevant to practice building.